Eradicating deadly staph using a new breed of antibiotics has revealed promising results in research released by QUT, to help overcome one of the biggest modern medical challenges.
The bacteria attach to medical devices including catheters, artificial joints, implants and patients’ burns and wounds, establishing bacterial biofilms, a leading cause of failing antibiotic therapies and chronic infections.
QUT researchers have developed hybrid antibiotics designed to penetrate the slimy shield protecting invasive golden staph (Staphylococcus aureus) infections.
Led by Associate Professor Makrina Totsika and PhD student Anthony Verderosa (pictured below), the research has been published in top infectious diseases journal Antimicrobial Agents and Chemotherapy.
The study found hybrid antibiotics worked well by destroying Staph biofilms grown in the lab.
“Biofilms are a sticky, slimy coating that often prevents conventional antibiotics from accessing bacterial cells,” Mr Verderosa said.
“We have developed a new breed of antibiotic that tricks biofilms into releasing their protected cells allowing access through the protective slimy coating of the biofilm.
“This allows for the biofilms to be eradicated.”
He said the microscopic compound emits a fluorescence signal enabling researchers to watch the drug penetrating the biofilm, either killing the bacteria directly or leaving them susceptible to killing.
Associate Professor Totsika said the majority of infections, even those not associated with an implanted medical device, involve biofilms in some way so the potential for these drugs is wide.
“We are now gearing up to do pre-clinical testing,” she said.
“What is promising is the fact that our compounds are hybrids of drugs that are already in clinical use as stand-alone therapies, such as conventional antibiotics and nitroxides, so this offers hope that they could be translated into clinical therapies in the not so distant future.”
Hospital acquired infections and increasing resistance to antibiotics has challenged medical researchers to find and test novel antimicrobial agents, including alternatives to antibiotics.
The World Health Organisation has identified antibiotic resistant pathogens as one of the “biggest threats to global health today”.
Associate Professor Totsika said there was scope to apply the research beyond medicine, to agriculture, biotechnology and other industries.
Go deeper with Bing News on:
- ‘World’s biggest’ piece of cell-based whole cut analogue developed: ‘Meatballs, burgers and nuggets have already been done’on January 26, 2021 at 7:08 pm
Novameat has made hybrid meat analogues which mix mammalian adipose cells ... of cells – there could be around 100trn cells in a single cow’s body – without antibiotics, standardising and synthetizing ...
- A hybrid additive manufacturing platform to create bulk and surface composition gradients on scaffolds for tissue regeneration | Nature Communicationson January 21, 2021 at 3:46 am
Additive Manufacturing has had a large impact on the biomedical field but still lacks tools to generate scaffolds with gradients of physico-chemical properties. Here the authors report on the design ...
- STU ELLIS: Try something different this timeon January 19, 2021 at 8:35 pm
It was a year ago when the White House and China announced they had an agreement to end the tariff war, and that China would buy $72 billion worth of ...
- Bacterial Type I Signal Peptidases as Antibiotic Targetson January 9, 2021 at 3:59 pm
The arrow indicates the point of cleavage and P1 and P3 residues are in bold. ‡A hybrid protein made up of signal peptide of outer membrane protein A from Escherichia coli and the nuclease A ...
- Chemo Drug Potentially More Potent than Remdesivir Against Coronaviruson January 5, 2021 at 12:13 pm
Two of the drugs, pralatrexate, a chemotherapy, and azithromycin, an antibiotic, were successful at preventing ... “We have demonstrated the value of our novel hybrid approach that combines ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Iron-carrying extracellular vesicles are key to respiratory viral-bacterial co-infectionon January 26, 2021 at 8:02 am
The mechanism by which acute viral respiratory infections promote secondary bacterial growth and infection in the airways depends on iron-carrying extracellular sacs secreted by the cells lining the ...
- Human organoid biofilm model for assessing antibiofilm activity of novel agentson January 24, 2021 at 4:00 pm
Bacterial biofilms cause 65% of all human infections and are highly resistant to antibiotic therapy but lack specific treatments. To provide a human organoid model for studying host-microbe interplay ...
- Family’s bills pile up as newborn fights deadly infectionon January 23, 2021 at 11:00 am
A young family unable to work while their newborn fights a life-threatening infection at a Coast hospital say bills are piling up.
- APM Stock: 9 Things to Know About Aptorum as Shares Fly on Staph Infection Drug Newson January 21, 2021 at 8:49 pm
Aptorum (NASDAQ: APM) stock is on the rise Wednesday after announcing approval to move forward with a Phase 1 clinical trial of its staph infection drug. Source: Bukhta Yurii / Shutterstock.com Here’s ...
- Hope for a vaccination against Staphylococcus areus infections?on January 21, 2021 at 8:15 am
Staphylococcus aureus (S. aureus) ranks among the globally most important causes of infections in humans and is considered a dreaded hospital pathogen. Active and passive immunization against ...